NASDAQ Composite opens in less than three hours and Catalyst Pharmaceuticals’s pre-market value is already 5.12% up.
The last session, NASDAQ Composite ended with Catalyst Pharmaceuticals rising 3.06% to $3.71. NASDAQ Composite dropped 0% to $13,635.99, after five consecutive sessions in a row of gains, on what was a somewhat positive trend trading session.
Catalyst Pharmaceuticals’s last close was $3.60, 42.32% below its 52-week high of $5.28.
Catalyst Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 1.94%, a positive 0.40%, and a positive 0.13%, respectively.
Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.69%, 4.25%, and 4.14%, respectively.